Bioxytran’s drug candidate, PHM23, utilizes a novel mechanism of action that targets galectin proteins critical to viral replication
PFAS free food packaging enabled by dry forming technology from YANGI
Integration of HiFi long-read whole-genome sequencing expands the collective capabilities of iHope’s global rare disease network
The aim of this project is to serve as a model case for AI adoption in public and general hospitals nationwide
In sepsis, the delay of even one hour in diagnosis can mean the difference between life and death. What if a standard blood test powered by AI, could flag the risk before symptoms even appear?
Proprietary multianalyte and multiomic assay with optimized machine learning capabilities achieve significantly higher 82% sensitivity and 97% specificity in high-risk populations
